LSL Pharma Group Inc (TSE:LSL) has released an update.
LSL Pharma Group Inc., a Canadian pharmaceutical company, has secured a $5 million loan from the Business Development Bank of Canada to pay off short-term debts and support growth initiatives. The loan will help fund the acquisition of Dermolab Pharma and the expansion of Steri-Med Pharma’s manufacturing capacity. This strategic move aims to enhance LSL Pharma’s financial performance and production capabilities.
For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.